Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-11

FDA Approved: PLERIXAFOR — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals LLC's supplemental application for plerixafor (generic) under an ANDA. This action approves a change to the product's la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plerixafor (Plerixafor)

Snippet

SUPPL AP for PLERIXAFOR (PLERIXAFOR)